mass spectrometric immunoassay
ProPhase Labs to Acquire Stella Diagnostics Esophageal Cancer Screening Test for $4.5M
The agreement gives ProPhase exclusive global rights to Stella's BE-Smart Esophageal Pre-Cancer screening test and related intellectual property assets.
Newborn Exome Sequencing Shows Potential to Help Find Inborn Errors of Metabolism
Exome sequencing had lower sensitivity and specificity for finding inborn errors of metabolism than conventional screening, but appeared to refine mass spec-based results.
Danaher Q4 Revenues Climb 6 Percent
Life Sciences revenues grew 7 percent year over year to $1.92 billion, while Diagnostics revenues were up rose also 7 percent to $1.80 billion.
Fluidigm Sues IonPath for Patent Infringement, Interference
The South San Francisco, California cellular analysis firm alleges IonPath has infringed two patents and has been intereferening in its contracts.
The new partnership will support the analysis of glycans in 30,000 human samples by the end of 2021.
Jan 29, 2019
Danaher Q4 Revenues Up 5 Percent
May 26, 2017
Sep 2, 2011
Apr 29, 2011
Apr 22, 2011
New Products: Apr 22, 2011
Premium
Jul 16, 2010